Medical treatment of ectopic pregnancy: a committee opinion. uri icon

Overview

abstract

  • Methotrexate, a folic acid antagonist, is an effective treatment for early unruptured ectopic pregnancy. Several treatment regimens are available. Methotrexate is more effective when used to treat ectopic pregnancies with lower human chorionic gonadotropin (hCG) levels. However, there is no consensus on a threshold value that best predicts success or failure. Methotrexate can be used to treat ectopic pregnancies that occur in cornual, cervical, and cesarean scar locations, and it does not adversely affect ovarian reserve or subsequent fertility. This document replaces the previous document of the same name, last published in 2008 (Fertil Steril 2008;90:S206-12).

publication date

  • July 10, 2013

Research

keywords

  • Abortifacient Agents
  • Pregnancy, Ectopic

Identity

Scopus Document Identifier

  • 84883444909

Digital Object Identifier (DOI)

  • 10.1016/j.fertnstert.2013.06.013

PubMed ID

  • 23849842

Additional Document Info

volume

  • 100

issue

  • 3